EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:145410 - EC 1.1.1.42 (isocitrate dehydrogenase) inhibitor
| ChEBI ID | CHEBI:145410 |
| ChEBI Name | EC 1.1.1.42 (isocitrate dehydrogenase) inhibitor |
| Stars | |
| Definition | An EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD+ or NADP+ acceptor) inhibitor that interferes with the action of any isocitrate dehydrogenase (EC 1.1.1.42). |
| Last Modified | 31 May 2022 |
| Submitter | Adnan |
| Wikipedia |
|---|
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| EC 1.1.1.42 (isocitrate dehydrogenase) inhibitor (CHEBI:145410) is a EC 1.1.1.* (oxidoreductase acting on donor CH-OH group, NAD+ or NADP+ acceptor) inhibitor (CHEBI:76835) |
| Incoming Relation(s) |
| enasidenib (CHEBI:145374) has role EC 1.1.1.42 (isocitrate dehydrogenase) inhibitor (CHEBI:145410) |
| ivosidenib (CHEBI:145430) has role EC 1.1.1.42 (isocitrate dehydrogenase) inhibitor (CHEBI:145410) |
| SYC-435 (CHEBI:189826) has role EC 1.1.1.42 (isocitrate dehydrogenase) inhibitor (CHEBI:145410) |
| ML309 (CHEBI:232356) is a EC 1.1.1.42 (isocitrate dehydrogenase) inhibitor (CHEBI:145410) |
| Synonyms | Source |
|---|---|
| IDP1 inhibitors | ChEBI |
| oxalosuccinate decarboxylase inhibitors | ChEBI |
| NADP isocitric dehydrogenase inhibitor | ChEBI |
| NADP+-ICDH inhibitors | ChEBI |
| isocitrate (NADP) dehydrogenase inhibitor | ChEBI |
| triphosphopyridine nucleotide-linked isocitrate dehydrogenase-oxalosuccinate carboxylase inhibitor | ChEBI |
| Manual Xrefs | Databases |
|---|---|
| Isocitrate_dehydrogenase | Wikipedia |